Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...

GSK has secured European Commission approval for Exdensur (depemokimab) to treat severe asthma with type 2 inflammation and ...

Lundbeck A/S has announced encouraging new data from the intravenous part of its phase 2b PROCEED trial, showing that ...

Muhunthan Thillai MD, co-founder and CEO, Qureight, commented: “Rebecca’s experience, expertise and people-centric leadership ...

Dr Michael Chen, CEO and co‑founder of Nuclera, said: “Scientists are under pressure to progress increasingly complex membrane protein programs faster. By partnering with leadXpro, we can pair ...

The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...

Enhanced Genomics, the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, has announced that Katerina ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...

In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...